Chir99021 and Valproic acid reduce the proliferative advantage of Apc mutant cells

Alistair J. Langlands; Thomas D. Carroll; Yu Chen; Inke Nathke

doi:10.1038/s41419-017-0199-9

Chir99021 and Valproic acid reduce the proliferative advantage of Apc mutant cells

Alistair J. Langlands, Thomas D. Carroll, Yu Chen, Inke Nathke (Lead / Corresponding author)

MRC PPU

Research output: Contribution to journal › Article › peer-review

17 Citations (Scopus)

261 Downloads (Pure)

Abstract

More than 90% of colorectal cancers carry mutations in Apc that drive tumourigenesis. A ‘just-right’ signalling model proposes that Apc mutations stimulate optimal, but not
excessive Wnt signalling, resulting in a growth advantage of Apc mutant over wild-type cells. Reversal of this growth advantage constitutes a potential therapeutic approach. We utilized intestinal organoids to compare the growth of Apc mutant and wild-type cells. Organoids derived from ApcMin/+ mice re-capitulate stages of intestinal polyposis in culture. They eventually form spherical cysts that reflect the competitive growth advantage of cells that have undergone loss of heterozygosity (LOH). We discovered that this emergence of cysts was inhibited by Chiron99021 and Valproic acid, which potentiates Wnt signalling. Chiron99021 and Valproic acid restrict the growth advantage of Apc mutant cells while stimulating that of wild-type cells, suggesting that excessive Wnt signalling reduces the relative fitness of Apc mutant cells. As a proof of concept, we demonstrated that Chiron99021–treated Apc mutant organoids were rendered susceptible to TSA-induced apoptosis, while wild-type cells were protected.

Original language	English
Article number	255
Pages (from-to)	1-10
Number of pages	10
Journal	Cell Death and Disease
Volume	9
DOIs	https://doi.org/10.1038/s41419-017-0199-9
Publication status	Published - 15 Feb 2018

ASJC Scopus subject areas

Immunology
Cellular and Molecular Neuroscience
Cell Biology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41419-017-0199-9Licence: CC BY

Final Published Version
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Final published version, 1.77 MBLicence: CC BY

Cite this

@article{bbb918ceb4d145bab5343ea7cadf500e,

title = "Chir99021 and Valproic acid reduce the proliferative advantage of Apc mutant cells",

abstract = "More than 90% of colorectal cancers carry mutations in Apc that drive tumourigenesis. A {\textquoteleft}just-right{\textquoteright} signalling model proposes that Apc mutations stimulate optimal, but notexcessive Wnt signalling, resulting in a growth advantage of Apc mutant over wild-type cells. Reversal of this growth advantage constitutes a potential therapeutic approach. We utilized intestinal organoids to compare the growth of Apc mutant and wild-type cells. Organoids derived from ApcMin/+ mice re-capitulate stages of intestinal polyposis in culture. They eventually form spherical cysts that reflect the competitive growth advantage of cells that have undergone loss of heterozygosity (LOH). We discovered that this emergence of cysts was inhibited by Chiron99021 and Valproic acid, which potentiates Wnt signalling. Chiron99021 and Valproic acid restrict the growth advantage of Apc mutant cells while stimulating that of wild-type cells, suggesting that excessive Wnt signalling reduces the relative fitness of Apc mutant cells. As a proof of concept, we demonstrated that Chiron99021–treated Apc mutant organoids were rendered susceptible to TSA-induced apoptosis, while wild-type cells were protected.",

author = "Langlands, {Alistair J.} and Carroll, {Thomas D.} and Yu Chen and Inke Nathke",

note = "We would like to thank members of the N{\"a}thke laboratory for general assistance and helpful discussions with particular thanks to Ian Newton for technical help. Microscopy and image analysis support was provided by the Dundee Light Microscopy and Tissue Imaging Facility funded by the Welcome Trust Technology Platform award (097945/B/11/Z) and Welcome trust award (101468/Z/13/Z). We are grateful for help from Dr. Rosie Clarke of the Flow Cytometry and Cell Sorting Facility at the University of Dundee, which is supported by Wellcome Trust award (097418/Z/11/Z). This work was supported by a program grant from Cancer Research UK to I.S.N (C430/A11243) that supported A.J.L., an MRC studentship that supported T.D.C. and a project award from NC3R (NC/M001156/1) that supported Y.C.",

year = "2018",

month = feb,

day = "15",

doi = "10.1038/s41419-017-0199-9",

language = "English",

volume = "9",

pages = "1--10",

journal = "Cell Death and Disease",

issn = "2041-4889",

publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Chir99021 and Valproic acid reduce the proliferative advantage of Apc mutant cells

AU - Langlands, Alistair J.

AU - Carroll, Thomas D.

AU - Chen, Yu

AU - Nathke, Inke

N1 - We would like to thank members of the Näthke laboratory for general assistance and helpful discussions with particular thanks to Ian Newton for technical help. Microscopy and image analysis support was provided by the Dundee Light Microscopy and Tissue Imaging Facility funded by the Welcome Trust Technology Platform award (097945/B/11/Z) and Welcome trust award (101468/Z/13/Z). We are grateful for help from Dr. Rosie Clarke of the Flow Cytometry and Cell Sorting Facility at the University of Dundee, which is supported by Wellcome Trust award (097418/Z/11/Z). This work was supported by a program grant from Cancer Research UK to I.S.N (C430/A11243) that supported A.J.L., an MRC studentship that supported T.D.C. and a project award from NC3R (NC/M001156/1) that supported Y.C.

PY - 2018/2/15

Y1 - 2018/2/15

N2 - More than 90% of colorectal cancers carry mutations in Apc that drive tumourigenesis. A ‘just-right’ signalling model proposes that Apc mutations stimulate optimal, but notexcessive Wnt signalling, resulting in a growth advantage of Apc mutant over wild-type cells. Reversal of this growth advantage constitutes a potential therapeutic approach. We utilized intestinal organoids to compare the growth of Apc mutant and wild-type cells. Organoids derived from ApcMin/+ mice re-capitulate stages of intestinal polyposis in culture. They eventually form spherical cysts that reflect the competitive growth advantage of cells that have undergone loss of heterozygosity (LOH). We discovered that this emergence of cysts was inhibited by Chiron99021 and Valproic acid, which potentiates Wnt signalling. Chiron99021 and Valproic acid restrict the growth advantage of Apc mutant cells while stimulating that of wild-type cells, suggesting that excessive Wnt signalling reduces the relative fitness of Apc mutant cells. As a proof of concept, we demonstrated that Chiron99021–treated Apc mutant organoids were rendered susceptible to TSA-induced apoptosis, while wild-type cells were protected.

AB - More than 90% of colorectal cancers carry mutations in Apc that drive tumourigenesis. A ‘just-right’ signalling model proposes that Apc mutations stimulate optimal, but notexcessive Wnt signalling, resulting in a growth advantage of Apc mutant over wild-type cells. Reversal of this growth advantage constitutes a potential therapeutic approach. We utilized intestinal organoids to compare the growth of Apc mutant and wild-type cells. Organoids derived from ApcMin/+ mice re-capitulate stages of intestinal polyposis in culture. They eventually form spherical cysts that reflect the competitive growth advantage of cells that have undergone loss of heterozygosity (LOH). We discovered that this emergence of cysts was inhibited by Chiron99021 and Valproic acid, which potentiates Wnt signalling. Chiron99021 and Valproic acid restrict the growth advantage of Apc mutant cells while stimulating that of wild-type cells, suggesting that excessive Wnt signalling reduces the relative fitness of Apc mutant cells. As a proof of concept, we demonstrated that Chiron99021–treated Apc mutant organoids were rendered susceptible to TSA-induced apoptosis, while wild-type cells were protected.

UR - http://www.scopus.com/inward/record.url?scp=85042174896&partnerID=8YFLogxK

U2 - 10.1038/s41419-017-0199-9

DO - 10.1038/s41419-017-0199-9

M3 - Article

C2 - 29449562

SN - 2041-4889

VL - 9

SP - 1

EP - 10

JO - Cell Death and Disease

JF - Cell Death and Disease

M1 - 255

ER -

Chir99021 and Valproic acid reduce the proliferative advantage of Apc mutant cells

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Mechanisms of Intestinal Epithelial Responses to Inflammatory Modulators

Sonopill: Minimally Invasive Gastrointestinal Diagnosis and Therapy (Joint with University of Glasgow & Heriot Watt University)

Nathke, Inke

Cite this

Chir99021 and Valproic acid reduce the proliferative advantage of Apc mutant cells

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Projects

Mechanisms of Intestinal Epithelial Responses to Inflammatory Modulators

Sonopill: Minimally Invasive Gastrointestinal Diagnosis and Therapy (Joint with University of Glasgow & Heriot Watt University)

Profiles

Nathke, Inke

Cite this